Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks 
Samsung Union Confirms 18-Day Strike After Failed Wage Talks 
Samsung Faces Major Strike Threat as Union Restarts Pay Talks 
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares 
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop 
OpenAI Expands Globally with First Overseas AI Lab in Singapore 
Tencent Shares Jump 4% as AI Models Move Toward Paid Commercial Services 
NHS shakeup: if it sounds like we’ve been here before, it’s because we have 
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition 
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism 
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower 
GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
